Norethindrone clinical trials
Also written Micronor.
Includes 27 studies of Norethindrone Acetate and 2 studies of Norethindrone enanthate.
Counted the way a researcher would: Norethindrone with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses Norethindrone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Norethindrone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 21 May 1962 · ORTHO-NOVUM 1/50 21 · NDA 012728 (FDA, Drugs@FDA; in a combination)
- European Union
- 16 Jul 2021 · Ryeqo · EMEA/H/C/005267 (EMA; as Norethindrone Acetate; in a combination)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
44 studies that test it; most in 2007 (8)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 8 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 3 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2024 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 22 · Other 22
AbbVie (4) · Novo Nordisk A/S (4) · Teva Pharmaceuticals USA (4) · Warner Chilcott (3) · University of Southern California (2) · Boston Children's Hospital (2) · Nobelpharma (2) · University of Sao Paulo (1)
Often tested with
Tested in the same studies.
Estradiol (13) · Ethinyl Estradiol (10) · Elagolix (5) · Trametinib (1) · Ethinyl estradiol, levonorgestrel drug combination (1) · Estrogens (1) · Colchicine (1) · VI-0521 (1)
Studies
Open first, then newest update. How each study uses Norethindrone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 44
- Brain and Blood Vessel Health Following Endometriosis Treatment in People With EndometriosisNot yet recruitingPhase 4Colorado State UniversityNCT07799246Written as Investigate how norethindrone acetate, a commonly used medication used to treat symptoms of endometriosis, impact biomarkers of brain health
- Ovulation Incidence in Oral Contraceptive UsersCompletedPhase 3University of Southern CaliforniaNCT03106454Written as Ethinyl Estradiol, Norethindrone acetate, ferrous fumarate
- Phenotyping of Idiopathic Pelvic Pain With Real-time Uterine Imaging and Relugolix-Combination Therapy TreatmentWithdrawnPhase 2Endeavor HealthNCT06279195Written as Relugolix (40 mg) /estradiol (1 mg)/norethisterone acetate (0.5 mg) oral tablet
- Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal WomenCompletedPhase 3AbbVieNCT03271489Written as Estradiol /norethindrone acetate (E2/NETA)
- IUD and Norethindrone Acetate for Treatment of EndometriosisWithdrawnPhase 2Boston Children's HospitalNCT04948489Written as norethindrone acetate (NETA)
- A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated PainCompletedPhase 3AbbVieNCT03213457Written as Estradiol/Norethindrone Acetate
- Treatment of Prolonged Uterine Bleeding of Etonogestrel (ENG)-Releasing ImplantCompletedPhase 4University of Sao PauloNCT04047875Written as Norethisterone 10mg/day
- Metabolism of 0.35mg Norethindrone vs 5mg Norethindrone AcetateCompletedPhase 4Milton S. Hershey Medical CenterNCT05294341Written as Norethindrone Acetate 5 MG
- Progestin-Only Pill Use and Breastfeeding StudyCompletedPhase 4University of California, San DiegoNCT04965116Written as Progestin Only Contraceptive Pills
- Effects of a Progestin on Frequent and/or Prolonged Bleeding With Nexplanon™TerminatedPhase 4Baylor Research InstituteNCT04676061Written as Norethindrone acetate (NTA)
- The Effect of Dienogest vs. Norethindrone Acetate Treatment in EndometriosisCompletedNot applicableUludag UniversityNCT05476172Written as Norethindrone Acetate
- A Trial of Norethisterone Acetate and Expectant Management in Treatment of Simple Ovarian CystsStatus unknownPhase 4Assiut UniversityNCT05293574Written as norethisterone acetate
- Use of Norethindrone Acetate for Management of Bleeding Associated With the Etonogestrel Contraceptive ImplantCompletedNot applicableNorton HealthcareNCT02353247Written as Norethindrone acetate
- A Drug-Drug Interaction Study to Assess the Effect of Trametinib on the Pharmacokinetics of an Oral Contraceptive in Female Patients With Solid TumorsCompletedPhase 1Novartis PharmaceuticalsNCT02705963Written as Oral Contraceptive (1mg norethindrone, 0.035mg ethinyl estradiol)
- Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)CompletedPhase 3AbbVieNCT02691494Written as Estradiol/Norethindrone Acetate
- Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal WomenCompletedPhase 3AbbVieNCT02654054Written as Estradiol/Norethindrone Acetate
- Effects of Tranexemic Acid Versus Norethisterone Acetate on Endometrial Vasculature .Status unknownPhase 3Cairo UniversityNCT04290013Written as norethisterone acetate
- The Effect of Norethisterone Enanthate on Recurrent Bacterial VaginosisCompletedPhase 4London School of Hygiene and Tropical MedicineNCT02905890Written as Norethisterone enantate
- Estrogen Diastolic Heart FailureTerminatedPhase 4Gretchen WellsNCT02693002Written as Estradiol/Norethindrone acetate
- Norethindrone for the Delay of MenstruationCompletedPhase 4Wayne State UniversityNCT03594604Written as Norethindrone
See all 44 studies that test Norethindrone →
Given beside what is tested · 17 — Norethindrone is usual care or a partner of the new treatment
- Cannabidiol and Management of Endometriosis PainTerminatedPhase 3Milton S. Hershey Medical CenterNCT04527003Written as Norethindrone Acetate
- Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsCompletedPhase 3Myovant Sciences GmbHNCT03751124Written as Estradiol/norethindrone acetate
- LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsCompletedPhase 3Myovant Sciences GmbHNCT03412890Written as Estradiol/norethindrone acetate
- SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated PainCompletedPhase 3Myovant Sciences GmbHNCT03654274Written as Estradiol/norethindrone acetate
- Low-Dose Naltrexone in Combination With Standard Treatment in Women With EndometriosisTerminatedPhase 3Milton S. Hershey Medical CenterNCT03970330Written as Norethindrone Acetate
- LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsCompletedPhase 3Myovant Sciences GmbHNCT03103087Written as Estradiol/norethindrone acetate
- LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsCompletedPhase 3Myovant Sciences GmbHNCT03049735Written as Estradiol/norethindrone acetate
- An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsCompletedPhase 3AbbVieNCT02925494Written as Estradiol/Norethindrone Acetate
- SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated PainCompletedPhase 3Myovant Sciences GmbHNCT03204331Written as Estradiol/norethindrone acetate
- SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated PainCompletedPhase 3Myovant Sciences GmbHNCT03204318Written as Estradiol/norethindrone acetate
- Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)CompletedPhase 2AbbVieNCT01817530Written as 0.5 mg estradiol / 0.1 mg norethindrone acetate
- Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and MidazolamCompletedPhase 1BayerNCT03353857Written as Norethindrone/ Noriday
- A Study to Evaluate Safety and Efficacy of Elagolix in Participants With Endometriosis With Associated Moderate to Severe PainTerminatedPhase 3AbbVieNCT03343067Written as estradiol/norethindrone acetate (E2/NETA)
- Estriol Treatment in Multiple Sclerosis (MS): Effect on CognitionStatus unknownPhase 2University of California, Los AngelesNCT01466114Written as Norethindrone
- A Study to Investigate the Effect of JNJ-63623872 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and NorethindroneCompletedPhase 1Janssen Research & Development, LLCNCT02652650Written as Norethindrone
- Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian FailureCompletedPhase 2/3Erasme University HospitalNCT01160315Written as Norethisterone acetate
- A Study of Pharmacokinetic Drug Interaction Study of the Hedgehog Pathway Inhibitor GDC-0449 in Combination With Rosiglitazone or Combined Oral Contraceptive in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy ExistsCompletedPhase 1Genentech, Inc.NCT01209143Written as Norethindrone/ethinyl estradiol
As the comparator · 4 — what is tested is compared with Norethindrone
- A Randomized Feasibility Trial Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in PreeclampsiaNot yet recruitingPhase 4Oregon Health and Science UniversityNCT07293728Written as Norethindrone 0.35 MG
- Dopamine Receptor Agonist Therapy for Pain Relief in Women Suffering From Endometriosis: A Pilot StudyCompletedPhase 2Boston Children's HospitalNCT02542410Written as Norethindrone acetate
- Efficacy of LNG-IUS for Treatment of Non-atypical Endometrial Hyperplasia in Perimenopausal WomenCompletedNot applicableMansoura UniversityNCT01499602Written as Norethisterone Acetate tablets
- Genistein and Endometrial HyperplasiaCompletedPhase 2University of MessinaNCT00453960Written as Norethisterone Acetate
Codes
What other systems call Norethindrone · ClinicalTrials.gg INT007908
- MeSH (NLM) D009640NorethindroneConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) T18F433X4SNORETHINDRONEConfirmed FDA, NLM
- RxNorm 7514One source FDA
- NCI Thesaurus C62059NorethindroneOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D009640 | Norethindrone | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | T18F433X4S | NORETHINDRONE | Confirmed FDA, NLM |
| RxNorm | 7514 | — | One source FDA |
| NCI Thesaurus | C62059 | Norethindrone | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.